InvestorsHub Logo
Post# of 252497
Next 10
Followers 75
Posts 4693
Boards Moderated 0
Alias Born 09/06/2003

Re: DewDiligence post# 109197

Thursday, 11/18/2010 2:21:28 PM

Thursday, November 18, 2010 2:21:28 PM

Post# of 252497

DNDN’s executives repeatedly boast that Provenge “fundamentally changes the treatment of prostate cancer” when, in actuality, Provenge changes almost nothing for patients who suffer from the disease.



I do think that Provenge does create some paradigm shifts:

a) It probably has the least SAEs of any solid metastatic tumor treatment in existance. (If there is some other treatment as benign I would like to be corrected.)

b) It is the first cancer vaccine. As such it will allow people to better understand how it works and build the next one - and improve on it.

FWIW.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.